Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The leading academic who has overseen the expansion of world-leading medical research at the NIHR Oxford Biomedical Research Centre (BRC) for the past nine years is stepping down. Professor Keith Channon will be replaced as Director of the Oxford BRC by Professor Helen McShane, a leading vaccine specialist.

Helen McShane for web.jpg

Professor Helen McShane

Prof Channon was appointed to lead the BRC, one of the National Institute of Health Research’s largest research centres, in 2009. He has overseen two successful bids for government funding to carry out research that benefits NHS patients: for £95.5m in 2012; and £113.7m for the period from 2017 to 2022, to support research across 20 medical themes.

The NIHR Oxford BRC is based at Oxford University Hospitals (OUH) NHS Foundation Trust and run in partnership with the University of Oxford.

Find out more (Oxford BRC website)